Expression Profile of BCL-2, BCL-X-L, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

导出原文传递

翻译打印收藏纠错

作者： Punnoose, Elizabeth A. ^[1] ; Leverson, Joel D. ^[2] ; Peale, Franklin ^[3] ; Boghaert, Erwin R. ^[4] ; Belmont, Lisa D. ^[5] ; Tan, Nguyen ^[6] ; Young, Amy ^[7] ; Mitten, Michael ^[8] ; Ingalla, Ellen ; Darbonne, Walter C. ; Oleksijew, Anatol ; Tapang, Paul ; Yue, Peng ; Oeh, Jason ; Lee, Leslie ; Maiga, Sophie ; Fairbrother, Wayne J. ; Amiot, Martine ; Souers, Andrew J. ; Sampath, Deepak

作者单位： Genentech Inc, Res Pathol, San Francisco, CA 94080 USA ^[1] Genentech Inc, Translat Oncol, San Francisco, CA 94080 USA ^[2] AbbVie Inc, Oncol Dev, N Chicago, IL USA ^[3] Genentech Inc, Early Discovery Biochem, San Francisco, CA 94080 USA ^[4] Univ Nantes, CNRS UMR6299, INSERM UMR892, Nantes, France ^[5] Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA ^[6] AbbVie Inc, Oncol Discovery, N Chicago, IL USA ^[7] Genentech Inc, Oncol Biomarkers, San Francisco, CA 94080 USA ^[8]

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Molecular cancer therapeutics

2016年15卷5期

1132-1144页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Expression Profile of BCL-2, BCL-X-L, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Expression Profile of BCL-2, BCL-X-L, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

检索历史清除